5/6/2022Drug R&D and Product Registration News Digest May 2022 (1)

5/6/2022Recent Executive Moves

5/5/2022EyePoint Signs Expanded License Deal with Betta Pharma for EYP-1901 in...

5/5/2022China's 88 firms Including Sinovac Added to SEC List for Possible Deli...

5/4/2022NiKang and Hansoh Announce Strategic Collaboration and License Deal fo...

5/4/2022Intravacc Enters Licensing Deal with Zhifei Lvzhu Biopharma for Whoopi...

5/4/2022BeiGene/Amgen Granted CN Conditional Approval of BLINCYTO (Blinatumo...

5/4/2022How American Companies are Approaching China's Data, Privacy, and Cybe...

5/3/2022International Cooperation Under China's Proposed Implementing Rules Fo...

5/3/2022Navigating The Latest Changes In China's Regulation Of Human Genetic R...

5/2/2022China in Lockdown Mode … Are Long Term Prospects and Bright Spots Sti...

5/2/2022China Continues to Drop Reimbursements via DIP system: PBM

5/2/2022U.S. FDA Snubs Two More China Only-Tested New Drugs from Hutchmed and ...

5/2/2022Merck's MilliporeSigma Invests €100M to Accelerate Single-Use Manufac...

5/2/2022Former GSK Scientist Convicted of Stealing Trade Secrets To Benefit Ch...

5/2/2022Pfizer Wins Chinese Approval of lorlatinib for ALK-positive Advanced N...

4/29/2022Novartis Reports Performance in Q1/2022 with China Business Up 16%

4/29/2022CDE Seeks Participation for Questionnaire Survey on Pediatric Drug R&D...

4/29/2022BMS and Chinese Partner LianBio Won FDA Nod for Camzyos to Treat Hea...

4/29/2022NHSA and NHC Issue Notice to Improve National 6th VBP (Insulin Program...

4/29/2022Recent Executive Moves

4/29/2022Drug R&D and Product Registration News Digest April 2022 (4)

4/29/2022Financial-related Company News Digest

4/29/2022Adagene-Sanofi's $2.5B Deal Tops March Deals in China (PharmaDJ)

4/28/2022The Three Key Drivers That Are Shaping China's Cell and Gene Therapy I...

4/28/2022Biotech Venture Capital Investment in China Climbs (WSJ)

4/28/2022NMPA Holds Meeting to Review Vaccine Regulatory Quality Management Sys...

4/28/2022Stevanato Group Acquires Manufacturing Facility in Zhejiang to Suppor...

4/28/2022Sales Expenditures of Listed Chinese Pharma Companies Sharply Up Again...

4/28/2022SMEI Revises Down Chinese Pharma Industry Growth Projection in 2022

Page:142/775 Total number of articles:23243: [First][<<] [140] [141] [142] [143] [144] [>>] [End]